Physician profile
Steven Batash
NPI 1225029242
$10,984.14
in general payments reported to CMS, 2019-2025
20 companies · $15.25 in 2025
The $15.25 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,085 · 2020: $268 · 2021: $131 · 2022: $9,377 · 2023: $108 · 2025: $15.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $123.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $122.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Apollo Endosurgery US INC | $9,602.15 | 2019-2023 | Overstitch Endoscopic Suturing System |
| Abbvie INC. | $219.10 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $207.28 | 2019-2020 | |
| Gilead Sciences, INC. | $166.29 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $124.70 | 2019-2020 | |
| Allergan, INC. | $116.64 | 2019-2020 | |
| Pfizer INC. | $87.52 | 2019 | |
| Concordia Pharmaceuticals INC. | $63.36 | 2019 | |
| Currax Pharmaceuticals LLC | $58.75 | 2022-2023 | Contrave |
| Intercept Pharmaceuticals, INC. | $57.66 | 2019-2020 | |
| Daiichi Sankyo INC. | $43.57 | 2019-2020 | |
| Fujifilm Healthcare Americas Corporation | $38.82 | 2023 | Fujifilm |
| Shionogi INC | $35.97 | 2019 | |
| Vivus LLC | $29.96 | 2019 | |
| Cook Medical LLC | $28.57 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Braintree Laboratories, INC. | $28.38 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $22.17 | 2019 | |
| Redhill Biopharma INC. | $20.64 | 2020 | |
| Novo Nordisk INC | $17.36 | 2020 | |
| Boston Scientific Corporation | $15.25 | 2025 | Overstitch Nxt Endoscopic Suturing System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Batash listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.